MTOR and colorectal carcinoma: In summary, we have shown that SIGIRRΔE8 promotes human CRC through 2 synergistic mechanisms: (1) it relieves the inhibition on TLR/IL-1R signaling through its dominant negative effect on full-length SIGIRR, enhancing the activation of NFκB and mTOR.